nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2020, 03, v.36;No.207 6-11
基于数据挖掘的全国各地区运用中医药防治新型冠状病毒肺炎的用药规律研究
基金项目(Foundation): 国家自然科学基金委员会地区科学基金项目(编号:81760848、 81360534)
邮箱(Email):
DOI: 10.13412/j.cnki.zyyl.20200407.006
发布时间: 2020-04-07
出版时间: 2020-04-07
网络发布时间: 2020-04-07
移动端阅读
摘要:

目的:应用数据挖掘方法探讨全国各地区运用中医药防治新型冠状病毒肺炎(COVID-19)的用药规律。方法:收集国家、各省、自治区、直辖市卫健委官网发布的诊疗方案,及中国知网、万方、维普三大数据库相关文献报道,运用Microsoft Excel 2003进行中药频数、性味、归经统计,通过SPSS Modeler 14.1软件所提供的Apriori算法进行关联规则分析,利用SPSS 23.0软件进行因子分析、聚类分析。结果:共筛选出212个中药处方,含162味中药。使用频数排名前4位的中药分别是甘草、杏仁、麻黄、藿香。排名前4位的药性分别为寒、温、微寒、平,药味为甘、苦、辛。从归经上看,归肺经、胃经最多。按功效分类,使用频数排名前4位的药物为清热药、解表药、补气药、补阴药。根据高频药物的关联规则分析,置信度最高的2组药分别为"杏仁→石膏、麻黄(100%)""杏仁→石膏、麻黄、甘草(100%)"。高频药物聚类分析成8类。结论:数据挖掘结果发现各地区防治COVID-19中医药处方中以清热补虚,固护脾胃为主,后期以补气药、补阴药居多,总结得出了常用药物使用特点,为临床上防治COVID-19提供一定的指导作用。

Abstract:

Objective:To analyze the medication regularity of traditional Chinese medicine compounds in preventing and treating COVID-19 based on data mining. Methods: Treatment guidelines of COVID-19 released by national government, different provinces, autonomous regions and municipalities were collected, as well as online databases, such as CNKI, WanFang medical network, and VIP database. After screening, statistics of use frequency, drug characteristic and flavor, channel tropism were performed by Excel 2003 software. Apriori algorithm in SPSS Modeler 14.1 software was used to analyze the association rules, SPSS 23.0 software was used to perform cluster analysis and factor analysis. Results: Among 212 compounds in this study, a total of 162 traditional Chinese medicines were involved. The top 4 drugs with the highest use frequency were Gancao(Glycyrrhizae Radix et Rhizoma), Xingren(Armeniacae Semen Amarum), Mahuang(Ephedra) and Huoxiang(Pogostemonis Herba). Drug characteristics are mainly concentrated on Han, Wen, Weihan and Ping. Drug flavors are mainly concentrated on Gan, ku and Xin flavor. Channel tropisms of the drugs are mainly belonged to Fei and Wei system. Frequency analysis showed that the main drugs in the prevention treatment of COVID-19 were Qingre drugs, Jiebiao drugs, Buqi drugs and Buyin drugs. According to the association rule analysis of core drugs, the two groups with the highest confidence were "Armeniacae Semen Amarum→Gypsum Fibrosum and ephedra(100%)", "Armeniacae Semen Amarum →Gypsum Fibrosum and ephedra and Glycyrrhizae Radix et Rhizoma(100%)". By the cluster analysis, eight clustering results were obtained. Conclusion: Data mining results suggests that the TCM compounds in preventing and treating COVID-19 are mostly focused on Qingrebuxu and Guhupiwei, while in later stage of COVID-19 disease, compounds of Buqi and Buyin drugs are mainly used. In the study, we summarized the regularity of commonly used drugs, in order to provide some guidance for the prevention and treatment of COVID-19 on clinic.

参考文献

[1]索继江,闫中强,刘运喜,等.新型冠状病毒肺炎医院感染现状及预防控制策略与措施探讨[J/OL].中华医院感染学杂志,1-6[2020-03-07].https://kns-cnki-net.webvpn.gxtcmu.edu.cn/kcms/detail/11.3456.R.20200228.1327.002.html.

[2]国家卫生健康委办公厅,国家中医药管理局办公室.关于进一步做好新型冠状病毒感染的肺炎,中西医结合救治工作通知[EB/OL].2020-01-27.http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-13/13053.html.

[3]新型冠状病毒肺炎诊疗方案(试行第六版)[J/OL].天津中医药,1-5[2020-03-07].https://kns-cnki-net.webvpn.gxtcmu.edu.cn/kcms/detail/12.1349.R.20200304.1638.006.html.

[4]任芳,刘硕.数据挖掘技术在医学信息中的广泛应用[J].中国多媒体与网络教学学报(上旬刊),2019,(6):9-10.

[5]彭丽坤.明清中医疫病发病、症状与用药相关性数据挖掘研究[D].南京中医药大学,2009.

[6]朱彦陈,赵海梅,高健,等.数据挖掘技术在中医现代化发展中的应用[J].江西中医药,2014,45(11):74-76.

[7]Nomura Toshihito,Fukushi Masaya,Oda Kosuke,et al.Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication In Vitro :Suppression of Viral Protein Synthesis by Glycyrrhizae Radix.[J].Evidence-based complementary and alternative medicine :eCAM,2019,2019.

[8]赵鑫,吕翠霞.《伤寒杂病论》杏仁析疑[J].中华中医药杂志,2019,34(5):2212-2214.

[9]滕俊,姜云宁,柴欣楼,等.中西医结合治疗新型冠状病毒肺炎研究进展[J/OL].中医学报,1-13[2020-03-08].https://kns-cnki-net.webvpn.gxtcmu.edu.cn/kcms/detail/41.1411.R.20200305.0737.002.html.

[10]孙增涛,安兴,肖玮,等.基于分期辨证论治探讨新型冠状病毒感染肺炎[J/OL].陕西中医药大学学报,2020,(2):1-9[2020-03-08].https://kns-cnki-net.webvpn.gxtcmu.edu.cn/kcms/detail/61.1501.R.20200211.1318.002.html.

[11]石岩,郜贺,赵亮,白长川.新型冠状病毒(2019-nCoV)感染的肺炎与风寒湿疫[J/OL].中华中医药学刊,1-7[2020-03-08].https://kns-cnki-net.webvpn.gxtcmu.edu.cn/kcms/detail/21.1546.R.20200211.0907.002.html.

[12]刘传华.麻杏石甘汤在临床治疗小儿支气管肺炎中的应用效果及对炎症指标的影响[J].心理月刊,2020,15(3):197.

[13]高琳,谢鸣,孙明瑜.柴芩合煎液与分煎液对LPS诱导的大鼠发热模型的影响[J].中国实验方剂学杂志,2003,(6):22-25.

[14]周梦玲,袁厚宇,吴素玲.麦冬多糖对脂多糖诱导巨噬细胞损伤的保护作用及机制研究[J].药学与临床研究,2019,27(6):416-420.

[15]徐海青,贾妮.论银翘散现代临床应用[J].辽宁中医药大学学报,2020,22(2):164-167.

[16]刘正元.《伤寒瘟疫条辨》学术思想概要及治温十五方用药规律研究[D].河南中医药大学,2017.

基本信息:

DOI:10.13412/j.cnki.zyyl.20200407.006

中图分类号:TP311.13;R259

引用信息:

[1]吴红英,许光兰,赵媚,等.基于数据挖掘的全国各地区运用中医药防治新型冠状病毒肺炎的用药规律研究[J].中药药理与临床,2020,36(03):6-11.DOI:10.13412/j.cnki.zyyl.20200407.006.

基金信息:

国家自然科学基金委员会地区科学基金项目(编号:81760848、 81360534)

发布时间:

2020-04-07

出版时间:

2020-04-07

网络发布时间:

2020-04-07

检 索 高级检索